Brief: Xvivo Perfusion: share warrant program fully subscribed
July 8 (Reuters) - Xvivo Perfusion AB XVIVO.ST :
* Upon full exercise of warrants, share capital increase is
around 5,500 Swedish crowns ($650) corresponding to a dilution
of about 0.9 percent of total number of shares and votes
Source text for Eikon: ID:nWkrgh3830
Further company coverage: XVIVO.ST
($1 = 8.5641 Swedish crowns)
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Xvivo Perfusion AB
See all newsSweden's XVIVO Q3 revenue beat expectations on thoracic sales
Brief: Xvivo Q3 EBIT SEK 28 Million
Brief: Xvivo Receives CE Certificates For Heart Preservation Technology
Brief: XVIVO Gets FDA Approval For Additional Patient Enrollment
Sweden's XVIVO Q2 sales beat estimates, helped by thoracic segment strength